- Home
- PCVX vs SNV Comparison
PCVX vs SNV Comparison
Compare PCVX & SNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- SNV
- Stock Information
- Founded
- PCVX 2013
- SNV 1888
- Country
- PCVX United States
- SNV United States
- Employees
- PCVX N/A
- SNV N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- SNV Major Banks
- Sector
- PCVX Health Care
- SNV Finance
- Exchange
- PCVX Nasdaq
- SNV Nasdaq
- Market Cap
- PCVX 9.6B
- SNV 7.9B
- IPO Year
- PCVX 2020
- SNV N/A
- Fundamental
- Price
- PCVX $37.76
- SNV $46.72
- Analyst Decision
- PCVX Strong Buy
- SNV Buy
- Analyst Count
- PCVX 9
- SNV 19
- Target Price
- PCVX $147.50
- SNV $58.68
- AVG Volume (30 Days)
- PCVX 1.6M
- SNV 2.1M
- Earning Date
- PCVX 05-07-2025
- SNV 04-16-2025
- Dividend Yield
- PCVX N/A
- SNV 3.35%
- EPS Growth
- PCVX N/A
- SNV N/A
- EPS
- PCVX N/A
- SNV 3.03
- Revenue
- PCVX N/A
- SNV $1,852,496,000.00
- Revenue This Year
- PCVX N/A
- SNV $28.53
- Revenue Next Year
- PCVX N/A
- SNV $6.59
- P/E Ratio
- PCVX N/A
- SNV $15.36
- Revenue Growth
- PCVX N/A
- SNV N/A
- 52 Week Low
- PCVX $30.12
- SNV $33.44
- 52 Week High
- PCVX $121.06
- SNV $59.92
- Technical
- Relative Strength Index (RSI)
- PCVX 15.46
- SNV 41.84
- Support Level
- PCVX $68.36
- SNV $46.55
- Resistance Level
- PCVX $76.61
- SNV $49.53
- Average True Range (ATR)
- PCVX 3.45
- SNV 1.34
- MACD
- PCVX -2.06
- SNV 0.30
- Stochastic Oscillator
- PCVX 16.43
- SNV 49.09
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.